Biorphen® (phenylephrine) – New drug approval
October 22, 2019 - Eton Pharmaceuticals announced the FDA approval of Biorphen (phenylephrine) injection, for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.
Download PDF
